AMENDMENT OF THE 2023 FINANCIAL CALENDAR
LAVIPHARM
AMENDMENT OF THE 2023 FINANCIAL CALENDAR
Paiania, 27 April 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, and as part of providing accurate and timely information to the investment community, announces the amended Financial Calendar of 2023. The amendment refers to the Analysts' Annual Briefing that will take place with physical presence on Tuesday, 16 May 2023. The Financial Calendar is updated as follows:
|
Thursday, 4 May 2023 |
Announcement of update on the 1Q.2023 Financial Results |
|
Tuesday, 16 May 2023 |
Analysts' Annual Briefing will take place at Hellenic Fund and Asset Management Association (Athens Exchange, Room Hermes, at 9:30am) |
|
Thursday, 6 July 2023 |
Ordinary Annual Shareholders Meeting |
|
Thursday, 21 September 2023 |
Announcement of the 1H.2023 Financial Report |
|
Wednesday, 8 November 2023 |
Announcement of update on 9M.2023 Financial Results |
The Company will not distribute dividend for the FY 2022.
Lavipharm reserves the right to change the aforementioned dates, following relevant and timely notification to the public by amending the present, in accordance with the provisions of the ATHEX Rulebook.
###
For more information:
Investor Relations
Lavipharm
Tel.: +30 210 6691 121
Email : ir@lavipharm.com
AMENDMENT OF THE 2023 FINANCIAL CALENDAR